Pirfenidone in the Chronic Hypersensitivity Pneumonitis Treatment

NCT02496182 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Alveolitis Extrinsic Allergic
Pulmonary Fibrosis

Interventions

DRUG: Placebo
DRUG: Pirfenidone
DRUG: Pirfenidone

Sponsor

Grupo Medifarma, S. A. de C. V.